Results 131 to 140 of about 6,816 (177)

Antigenic profiling of Leishmania amazonensis microsomal fraction to support vaccine development. [PDF]

Parasitol Res
Fernandes JMP, Sena EPF, Schwarz MGA, Corrêa MBC, Hardoim DJ, Carneiro K, d' Escoffier LN, Souza CDSF, Zaverucha do Valle T, da Silva Calabrese K.   +9 more
europepmc   +1 more source

Impact of Bacterial Membrane Vesicles on Cellular Responses in Leishmania amazonensis-Infected Macrophages In Vitro. [PDF]

Scand J Immunol
Gallo-Francisco PH, Jorge GP, Roque GAS, E Silva MF, da Silva NS, Fagundes CC, Oliveira ALR, Almeida F, Brocchi M, Giorgio S.   +9 more
europepmc   +1 more source

Lipid Mediators in Host-Pathogen Interactions during <i>Leishmania</i> Infection: Friends or Foes? [PDF]

ACS Infect Dis
Andrade YMFS, Silva DA, Nascimento TLP, Sousa MO, Carvalho BLA, Lima JB, Borges VM, Araújo-Santos T.   +7 more
europepmc   +1 more source

Anti-Leishmania activated C-kinase monoclonal antibody immunohistochemical technique for cutaneous leishmaniasis diagnosis. [PDF]

PLoS One
Santos ADL, Pascoal-Xavier MA, Peruhype-Magalhães V, Eller MTC, Pereira FRV, Rodrigues MP, Brito MNP, E Silva BOS, Silva TRD, Avelar DM, Freire ML, Oliveira E.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

In vitro activity of cinnamaldehyde on Leishmania (Leishmania) amazonensis

Experimental Parasitology, 2022
Tegumentary leishmaniasis is an endemic disease that urgently needs new and effective treatments. L. amazonensis is one of the main species involved in the transmission of this infectious and non-contagious disease. The currently available treatments for leishmaniasis have high toxicity and vary in efficacy.
Aline Ávila Brustolin, Áquila Carolina Fernandes Herculano Ramos-Milaré, Tatiane França Perles de Mello, Sandra Mara Alessi Aristides, Maria Valdrinez Campana Lonardoni, Thaís Gomes Verzignassi Silveira   +5 more
openaire   +2 more sources

Antileishmanial activity of cordiaquinone E towards Leishmania (Leishmania) amazonensis

International Immunopharmacology, 2021
Leishmaniasis is caused by several protozoan species of Leishmania, and being endemically present in 98 countries around the world, it is also a severe public-health problem. The available antileishmanial drugs are toxic and yet present risks of recurrent infection. Efforts to find new, effective, and safe oral agents for the treatment of leishmaniasis
Raiza Raianne Luz, Rodrigues, Thaís Amanda Lima, Nunes, Alyne Rodrigues, de Araújo, José Delano Barreto, Marinho Filho, Marcos Vinícius, da Silva, Fernando Aécio de Amorim, Carvalho, Otília Deusdenia Loiola, Pessoa, Hozana Patrícia Silva, Freitas, Klinger Antonio da Franca, Rodrigues, Ana Jérsia, Araújo   +9 more
openaire   +2 more sources

Detection of Leishmania (Leishmania) amazonensis and Leishmania (Leishmania) infantum chagasi in Brazilian bats

Veterinary Parasitology, 2010
Although bats are one of the most abundant mammals in the new world and are present in virtually all ecosystems, including urban and peri-urban environments, few studies have investigated the role of these animals in the epidemiological chain of leishmaniosis.
Elisa San Martin Mouriz, Savani, Marilene Fernandes, de Almeida, Maria Cecília Gibrail, de Oliveira Camargo, Sandra Regina Nicoletti, D'Auria, Miriam Martos Sodré, Silva, Maria Lúcia, de Oliveira, Débora, Sacramento   +6 more
openaire   +2 more sources

Leishmania amazonensis response to artemisinin and derivatives

Parasitology International, 2021
The worldwide presence of Leishmania parasites increases in the poorest regions. Current leishmaniasis treatments are unsatisfactory due to resistance development, side effects and cost. Herein, we describe the in vitro activity of artemisinin (ART), artemether (ATM), artesunate (ATS) and dihydroartemisinin (DHA) against Leishmania amazonensis ...
Laura, Machín, Rachel, Nápoles, Lars, Gille, Lianet, Monzote   +3 more
openaire   +2 more sources

Characterization of Leishmania (Leishmania) amazonensis promastigotes resistant to pentamidine

Experimental Parasitology, 2008
Pentamidine is a second-line agent used in the treatment of leishmaniasis and its mode of action and mechanism of resistance is not well understood. It was previously demonstrated that transfection of promastigotes and amastigotes with the ABC transporter PRP1 gene confers resistance to pentamidine.
Adriano C, Coelho, Luciana G, Gentil, José Franco, da Silveira, Paulo C, Cotrim   +3 more
openaire   +2 more sources